{
  "paper_metadata": {
    "pmid": "36107942",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted variants in the BRCA2 gene along with penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.N372H",
      "protein_notation": "p.Asn124Hys",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "colorectal carcinoma with liver metastasis"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "colorectal carcinoma with liver metastasis",
          "evidence_sentence": "One sample was identified in the large intestine in a colorectal carcinoma with liver metastasis."
        }
      ],
      "functional_data": {
        "summary": "The N372H mutation is situated in a region between the PALB2 and RAD51 binding domains.",
        "assays": []
      },
      "segregation_data": "Not specified",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The mutation is associated with hypermutation and increased copy number variation.",
      "key_quotes": [
        "The commutated BRCA2 N372H is situated in a region between the PALB2 and RAD51 binding domains."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.G405R",
      "protein_notation": "p.Gly135Arg",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "endometrial carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "endometrial carcinoma",
          "evidence_sentence": "This sample had a mutation in the RAD52 homodimerization domain (A146V) and two mutations in BRCA2: G405R situated between the PALB2 and RAD51 interaction domains."
        }
      ],
      "functional_data": {
        "summary": "The G405R mutation is situated between the PALB2 and RAD51 interaction domains.",
        "assays": []
      },
      "segregation_data": "Not specified",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The sample was characterized by a C/G>T/A mutational signature indicative of an endogenous mutation process.",
      "key_quotes": [
        "This sample had a mutation in the RAD52 homodimerization domain (A146V) and two mutations in BRCA2: G405R situated between the PALB2 and RAD51 interaction domains."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.E1441*",
      "protein_notation": "p.Glu481*",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "endometrial carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "endometrial carcinoma",
          "evidence_sentence": "This sample had a mutation in the RAD52 homodimerization domain (A146V) and two mutations in BRCA2: G405R situated between the PALB2 and RAD51 interaction domains and E1441* which truncates the C-terminus from RAD51 binding domain/BRC repeats."
        }
      ],
      "functional_data": {
        "summary": "The E1441* mutation truncates the C-terminus from RAD51 binding domain/BRC repeats.",
        "assays": []
      },
      "segregation_data": "Not specified",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The sample was characterized by a C/G>T/A mutational signature indicative of an endogenous mutation process.",
      "key_quotes": [
        "This sample had a mutation in the RAD52 homodimerization domain (A146V) and two mutations in BRCA2: G405R situated between the PALB2 and RAD51 interaction domains and E1441* which truncates the C-terminus from RAD51 binding domain/BRC repeats."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 3,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted successfully."
  }
}